Last reviewed · How we verify
[¹⁴C]Opevesostat
At a glance
| Generic name | [¹⁴C]Opevesostat |
|---|---|
| Also known as | MK-5684 |
| Sponsor | Merck Sharp & Dohme LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- [¹⁴C]Opevesostat CI brief — competitive landscape report
- [¹⁴C]Opevesostat updates RSS · CI watch RSS
- Merck Sharp & Dohme LLC portfolio CI